ASND NASDAQ · Healthcare · FY 2025-12-31

Ascendis Pharma A/S

Back to NASDAQ
0.057.8115.7173.5231.3ABVnot valid for this companyEPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 214.20 EUR
0.065.9131.7197.6263.4ABVnot valid for this companyEPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 243.91 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in EURUSD
Verdict
Unknown
Buy zone
Unknown
Archetype
Distressed/Deficit
Confidence
○○○ Insufficient · 0/4
Price
214.20243.91 EURUSD *
Market cap
13.15B14.97B EURUSD *
P / B
-80.75
P / E
—
EPS
-3.760-4.281
DPS / yield
— (0.0%)
NAV / share
-2.713-3.089
Graham number
—
Z'' score
—
Piotroski F
5 / 9
Beneish M
-2.57
ROIC vs WACC
-129.3% vs 10.8%

* Listed in USD — the pipeline states price and all valuations in the filing currency EUR (fx 0.88 EUR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.